ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "work"

  • Abstract Number: 0123 • ACR Convergence 2023

    Improving Interpretation of Work Outcomes in Patients with Inflammatory Rheumatic Musculoskeletal Disease: General Population Reference Curves for Work Ability and At-work Productivity

    Dafne Capelusnik1, Wouter Smeets2, Casper Webers3, Sofia Ramiro4, Elena Nikiphorou5, Roel Braekers2, Laura Boekel6, Gertjan Wolbink7 and Annelies Boonen8, 1Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 2Data science institute, Hasselt University, Hasselt, Belgium, 3Maastricht University, Maastricht, Netherlands, 4Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 5King's College London, London, United Kingdom, 6Amsterdam Rheumatology and Immunology Center, Location Reade, Department of Rheumatology, Amsterdam, Netherlands, 7Reade, Amsterdam, Netherlands, 8Care and Public Health Research Institute (Caphri), Maastricht University, Maastricht, Netherlands

    Background/Purpose: Data on self-reported presenteeism (limitations or reduced work productivity at work) in persons with inflammatory rheumatic and musculoskeletal diseases (iRMD) are challenging to interpret…
  • Abstract Number: 0290 • ACR Convergence 2023

    Patient-reported Quality of Life and Working Status Outcomes in Ambulatory Patients with Idiopathic Inflammatory Myopathy

    Zhao Peng1, Yanhong Wang2, Ning Liu3, Shuang Zhou4, Jiuliang zhao1, Dong Xu5, Mengtao Li6, chanyuan wu4 and Qian Wang4, 1Peking Union Medical College, Beijing, China, 2Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 3Division of Rheumatology, Department of Medicine, The University of Hong Kong-Shenzhen Hospital, HongKong, China, 4Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 5Department of Rheumatology, Peking Union Medical College, Beijing, China, 6Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

    Background/Purpose: To investigate the health-related quality of life (HR-QoL), work productivity and activity impairment, and associated factors among patients with idiopathic inflammatory myopathy (IIM). Methods:…
  • Abstract Number: 0400 • ACR Convergence 2023

    Thresholds of Presenteeism Measurement Instruments for Unacceptable Work Participation and Future Adverse Work Outcomes in Rheumatoid Arthritis

    Dafne Capelusnik1, Sofia Ramiro2, Elena Nikiphorou3, Walter P. Maksymowych4, Marina Nighat Magrey5, Helena Marzo-Ortega6 and Annelies Boonen7, 1Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 2Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3King's College London, London, United Kingdom, 4University of Alberta, Edmonton, AB, Canada, 5Case Western Reserve University, University Hospitals, Cleveland, OH, 6NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 7Care and Public Health Research Institute (Caphri), Maastricht University, Maastricht, Netherlands

    Background/Purpose: Presenteeism is associated with lower work satisfaction and increased risk of future sick leave in rheumatic diseases. It is generally measured on a continuous…
  • Abstract Number: 0488 • ACR Convergence 2023

    Factors Associated with Work Productivity Among Individuals with Psoriatic Arthritis (PsA) and Psoriasis (PsO): The Role of Patient Reported Outcomes and Disease Severity

    Nancy Shadick1, Kumiko Schnock2, Vivi Feather3, Ruogu Li2, Jing Cui1, Shivani Patel2, Sabrina Goutier1, Muibat Yussuff2, Lourdes Perez-Chada2, Michael Weinblatt4 and Joseph Merola5, 1Brigham and Women's Hospital, Boston, MA, 2Brigham and Women's Hospital, Boston, MA, 3Mass General Brigham, Boston, MA, 4Harvard Medical School, Waban, MA, 5Harvard Medical School, Brigham and Women's Hospital, Newton, MA

    Background/Purpose: Patients with Psoriatic Arthritis (PsA) and Psoriasis (PsO) have an increased rate of work loss due to their disease compared the general population; however,…
  • Abstract Number: 0521 • ACR Convergence 2023

    Work Productivity Improved in Patients with Axial Spondyloarthritis Receiving Bimekizumab Treatment over 52 Weeks: Results from Two Phase 3 Studies

    Martin Rudwaleit1, Victoria Navarro-Compán2, Atul Deodhar3, Maureen Dubreuil4, Michael Frank Mørup5, Vanessa Taieb6, Christine de la Loge7, Carmen Fleurinck8, Ute Massow9, Thomas Vaux10 and Annelies Boonen11, 1University of Bielefeld, Klinikum Bielefeld, Bielefeld, Germany, 2Department of Rheumatology, La Paz University Hospital, IdiPaz, Madrid, Spain, 3Division of Arthritis and Rheumatic Disease, Oregon Health & Science University, Portland, OR, 4Department of Rheumatology, Boston University School of Medicine, Milton, MA, 5UCB Pharma, Copenhagen, Denmark, 6UCB Pharma, Colombes, France, 7UCB Pharma, Brussels, Belgium, 8UCB Pharma, Oosterzele, Belgium, 9UCB Pharma, Monheim am Rhein, Germany, 10UCB Pharma, Slough, United Kingdom, 11Care and Public Health Research Institute (Caphri), Maastricht University, Maastricht, Netherlands

    Background/Purpose: The clinical manifestations of axial spondyloarthritis (axSpA) limit physical function and work productivity, posing an economic burden to patients (pts) and society.1 Bimekizumab (BKZ),…
  • Abstract Number: 0650 • ACR Convergence 2023

    Understanding the Employment Landscape in People with Systemic Sclerosis

    Hila Jazayeri1, Zareen Ahmad1, Monique Gignac2 and Sindhu Johnson3, 1University of Toronto, Toronto, ON, Canada, 2Institute for Work & Health, Toronto, ON, Canada, 3Division of Rheumatology, Department of Medicine, Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western and Mount Sinai Hospitals; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Systemic sclerosis (SSc) is a systemic rheumatic disease that restricts participation in various life roles, including in the workplace. Our objectives were to identify…
  • Abstract Number: 1257 • ACR Convergence 2023

    The Psychological Experience of Work for People with Inflammatory Arthritis (IA)

    Joan Westreich1, Adena Batterman1, Anna Balakrishnan1, Roberta Horton1, Minerva Nong1, Vivian Bykerk2 and Theodore Fields1, 1Hospital for Special Surgery, New York, NY, 2Department of Rheumatology, Hospital for Special Surgery, New York, NY

    Background/Purpose: A large body of research reports that people with inflammatory arthritis (IA) are at increased risk for work disability, which profoundly affects all aspects…
  • Abstract Number: 1407 • ACR Convergence 2023

    Defining Thresholds of Presenteeism Measures for Unacceptable Work Participation in axSpA

    Dafne Capelusnik1, Sofia Ramiro2, Elena Nikiphorou3, Walter P. Maksymowych4, Marina Nighat Magrey5, Helena Marzo-Ortega6 and Annelies Boonen7, 1Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 2Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3King's College London, London, United Kingdom, 4University of Alberta, Edmonton, AB, Canada, 5Case Western Reserve University, University Hospitals, Cleveland, OH, 6NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 7Care and Public Health Research Institute (Caphri), Maastricht University, Maastricht, Netherlands

    Background/Purpose: Presenteeism is associated with lower work satisfaction and future sick leave in axial spondyloarthritis (axSpA). It is generally assessed as a continuous variable; however,…
  • Abstract Number: 1415 • ACR Convergence 2023

    Bimekizumab Treatment Impact on Work Productivity in Biologic DMARD‑Naïve and TNFi-IR Patients with Active Psoriatic Arthritis: Results up to 1 Year from Two Phase 3 Studies

    Philip J. Mease1, Dafna Gladman2, Laure Gossec3, Peter Nash4, Barbara Ink5, Jason Coarse6, Nikos Lyris5, Damon Willems7 and William R Tillett8, 1Swedish Medical Center/Providence St. Joseph Health and University of Washington School of Medicine, Seattle, WA, 2Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, Department of Medicine, University of Toronto, Toronto, ON, Canada, 3Sorbonne Université and Pitié Salpêtrière Hospital, Paris, France, 4School of Medicine, Griffith University, Brisbane, Australia, 5UCB Pharma, Slough, United Kingdom, 6UCB Pharma, Morrisville, NC, 7UCB Pharma, Brussels, Belgium, 8Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom

    Background/Purpose: PsA impacts the physical health and functional ability of patients (pts),which can contribute to reduced work productivity.1 Bimekizumab (BKZ) is a monoclonal IgG1 antibody…
  • Abstract Number: 1416 • ACR Convergence 2023

    Improvement of Work Absenteeism Following Start of Methotrexate Monotherapy in Newly-Diagnosed Psoriatic Arthritis

    Ulf Lindström1, Daniela Di Giuseppe2, Sofia Exarchou3, Gerd-Marie Alenius4, Tor Olofsson5, Eva Klingberg1, Lennart Jacobsson6, Johan Askling2 and Johan Karlsson Wallman5, 1University of Gothenburg, Gothenburg, Sweden, 2Karolinska Institutet, Stockholm, Sweden, 3Lund University, Åkarp, Sweden, 4Umeå University, Umeå, Sweden, 5Lund University and Skåne University Hospital, Lund, Sweden, 6University of Gothenburg, Malmö, Sweden

    Background/Purpose: In many countries, methotrexate (MTX) monotherapy is the first-line disease-modifying anti-rheumatic drug (DMARD) therapy for psoriatic arthritis (PsA), despite that its efficacy in PsA…
  • Abstract Number: 0237 • ACR Convergence 2022

    Whats Trending? A 12- year Analysis of International Medical Graduates Matching into Rheumatology Fellowship Programs in the United States

    Temitope Ajayi1, Arabi Rasendrakumar2, Kavish Singh3, Sladjana Skopelja-Gardner4 and Aakanksha Khanna5, 1University at Buffalo, Buffalo, NY, 2University of Buffalo, Buffalo, NY, 3Montefiore Medical Center, Brooklyn, NY, 4Dartmouth Hitchcock Medical Center, Lebanon, NH, 5Dartmouth-Hitchcock Medical Center, Lebanon, NH

    Background/Purpose: The goal of this study is to report the trends in the match results of International Medical Graduates (IMGs) from 2008-2020 into Rheumatology fellowship…
  • Abstract Number: 0376 • ACR Convergence 2022

    The Socioeconomic Profile of Patients with Radiographic Axial Spondyloarthritis Is Associated with the Severity of the Disease and with the Permanent Disability. a Cluster Analysis in a National Spanish Registry

    Clementina Lopez-Medina1, Desiree Ruiz-Vilchez2, Maria Angeles Puche Larrubia3, lourdes Ladehesa-Pineda4, Pilar Font5 and Eduardo Collantes5, 1Reina Sofia University Hospital, Rheumatology Department, Jaén, Spain, 2Reina Sofia University Hospital, Cordoba, Cordoba, Spain, 3Reina Sofia University Hospital/Rheumatology Department/Maimonides Institute for Biomedical Research (IMIBIC), Granada, Spain, 4Reina Sofia University Hospital/Rheumatology Department/Maimonides Institute for Biomedical Research (IMIBIC), Cordoba, Spain, 5IMIBIC/University of Cordoba/Reina Sofia Hospital, Cordoba, Spain

    Background/Purpose: Previous studies have demonstrated that male gender and higher level of education are independently associated with a lower hazard of sick leave in patients…
  • Abstract Number: 0882 • ACR Convergence 2022

    Gender Differences in Rheumatology Authorship: A Bibliometric Analysis of High Impact Rheumatology Journals from 2019-2021

    Neha Chaurasia1, Priyanka Iyer1 and Melody Esmaeili-Ghahfarokhi2, 1University of California Irvine, Orange, CA, 2University of California Irvine, Orange

    Background/Purpose: Recent data suggests the COVID-19 pandemic disproportionately affected productivity of women in the workforce. This bibliometric analysis examines gender differences in authorship of manuscripts…
  • Abstract Number: 0901 • ACR Convergence 2022

    Factors Associated with Household Work Limitations in Mexican Patients with Rheumatoid Arthritis: The Impact of the Disease on Women’s Life

    Ana Ortiz-Haro1, Irazu Contreras-Yáñez1, Guillermo Guaracha Basañez2 and Virginia Pascual Ramos3, 1Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, Mexico, 2Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirn", Ciudad de México, Mexico, 3Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Ciudad de México, Mexico

    Background/Purpose: Rheumatoid arthritis (RA) is the most frequent chronic inflammatory arthritis with a clear female preponderance. For various reasons, women spend more time on household…
  • Abstract Number: 1355 • ACR Convergence 2022

    Relationships Between Work Productivity, Activity Impairment, and Select Patient-Reported Outcomes in Patients with Ankylosing Spondylitis: A Post Hoc Analysis of Two Placebo-Controlled Trials

    Marina Magrey1, James Cheng-Chung WEI2, Arne Yndestad3, Andrew Bushmakin4, Joseph Cappelleri4, Oluwaseyi Dina5 and Atul Deodhar6, 1Case Western Reserve University, University Hospitals, Richfield, OH, 2Chung Shan Medical University Hospital, Taichung, Taiwan, 3Pfizer Inc, Oslo, Norway, 4Pfizer Inc, Groton, CT, 5Pfizer Inc, New York, NY, 6Oregon Health & Science University, Portland, OR, USA, Portland, OR

    Background/Purpose: Patients (pts) with AS often experience impaired work productivity.1 In pts with AS receiving tofacitinib (oral Janus kinase inhibitor), improvements were observed in work…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology